Or, R <br/><br/>
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients.  [electronic resource] 

 -  Transplantation  Apr 1996 
 - 1067-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-199604150-00014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Platelets--drug effects<br/>Bone Marrow Transplantation--adverse effects<br/>Female<br/>Fibrinolytic Agents--therapeutic use<br/>Heparin, Low-Molecular-Weight--therapeutic use<br/>Hepatic Veno-Occlusive Disease--prevention & control<br/>Humans<br/>Male<br/>Middle Aged